Retrospective comparative study on clinical remission rate and safety of rituximab combined with glucocorticoids versus cyclophosphamide monotherapy in patients with membranous nephropathy.

Medicine (Baltimore) · 2026 · PMC12851730 · PMID 41578483

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = .084so close (0.05 < p ≤ 0.1)

a clear trendno p-value reported

Although the difference in relapse rates between the 2 groups did not reach statistical significance (χ 2 = 3.00, P = .084), the RTX group exhibited a clear trend toward a lower relapse incidence.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.